Take a trial of Europe to unlock this pageFind out more
© Stockopedia 18th October, 2017

MDxHealth SA

MDXH €4.58 -0.0  -0.6%

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2011 2012 2013 2014 2015 2016 TTM 2017E 2018E CAGR / Avg
Revenue $m
Operating Profit $m
Net Profit $m
EPS Reported $
EPS Normalised $
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps $
Capex ps $
Free Cashflow ps $
Dividend ps $
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc $m
Working Capital $m
Net Fixed Assets $m
Net Debt $m
Book Value $m
Average Shares m
Book Value ps $ +6.1%

FINANCIAL BRIEF: For the six months ended 30 June 2017, MDxHealth SA revenues increased 87% to $24.3M. Net income totaled $538K vs. loss of $7.6M. Revenues reflect Royalties increase from $1.9M to $5.3M, Turnover increase of 10% to $12M. Net Income reflects Research and development expenses decrease of 21% to $832K (expense), Financial Expenses decrease of 42% to $86K (expense), Financial Income increase from $3K to $16K (income). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 30th Jun '17) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2017
31st Dec 2018

Price Target: €6.76
(+46.51% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (€) (€) (€) (€) (€) (€)
Consensus Estimate
1m Change
3m Change
3 brokers Broker Consensus Trend
Broker Recommendations for MDxHealth SA
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 1 1 2

Named Brokers and Analysts
Taglich Brothers Inc. Howard Halpern , ING FM Luke Poloniecki , Kempen & Co Alexandru Cogut , KBC Securities Michael Vlemmix , Petercam (Historical) Roderick Verhelst ,

Profile Summary

MDxHealth SA is a Belgium-based multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.

Directors: Jan Groen (CEO) 57, Jean-Marc Roelandt (CFO) 52, Joseph Sollee (EVP) 49, Christopher Thibodeau (EVP) 44, Mark Shaffar (NEC) 61, Rudi Marien (NED) 72, Jan Pensaert (NED) 45, Ruth Devenyns (NID) 51, Walter Narajowski (NID) 63,

No. of Employees: 162 No. of Shareholders: n/a

Last Annual December 31st, 2016
Last Interim June 30th, 2017
Incorporated January 15, 2003
Public Since June 28, 2006
Shares in Issue 49,949,408
Free Float 43.3m (86.8%)
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Euronext - Brussels
Eligible for an ISA? a SIPP?

MDXH Share Price Performance MDXHQuote
-0.0  -0.6%
Traded 4:35pm · Minimum 15 min delayed · NMS:

Latest MDXH News Announcements (delayed)

Upcoming MDXH Events

Recent ↓
Thursday 10th August, 2017
MDxHealth SA at Canaccord Genuity Growth Conference
Friday 26th May, 2017 (estimate)
MDxHealth SA Annual Shareholders Meeting
Friday 26th May, 2017
MDxHealth SA Annual Shareholders Meeting
Thursday 17th November, 2016
MDxHealth SA at Canaccord Genuity Med Tech Conference
Monday 12th September, 2016
MDxHealth SA at Rodman & Renshaw Global Investment Conference
Friday 27th May, 2016
MDxHealth SA Annual Shareholders Meeting
Tuesday 10th May, 2016
MDxHealth SA at Berenberg Diagnostics Conference
Tuesday 22nd March, 2016
MDxHealth SA at KBC Securities Institutional Healthcare Conference
Thursday 19th November, 2015
MDxHealth SA at Canaccord Genuity Medical Technology & Diagnostics Forum
Thursday 10th September, 2015
MDxHealth SA at Rodman & Renshaw Global Investment Conference
Thursday 19th March, 2015
MDxHealth SA at The Wall Street Analyst Institutional Investor Conference
Thursday 13th November, 2014
MDxHealth SA at KBC Belgian Biotech & Healthcare Seminar
Thursday 2nd October, 2014
MDxHealth SA at CF&B Large & Midcap Event
Tuesday 9th September, 2014
MDxHealth SA at Rodman & Renshaw Global Investment Conference
Thursday 21st August, 2014
Q2 2014 MDxHealth SA Earnings Release
Friday 30th May, 2014
MDxHealth SA Annual Shareholders Meeting
Friday 30th May, 2014
MDxHealth SA Extraordinary Shareholders Meeting

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2017.

Should you buy MDXH

Access MDXH Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis